Department of Pharmacokinetics and Pharmacodynamics and Global Center of Excellence Program, University of Shizuoka School of Pharmaceutical Sciences, Shizuoka, Japan.
Urology. 2010 Oct;76(4):1017.e7-12. doi: 10.1016/j.urology.2010.05.012. Epub 2010 Aug 16.
To clarify the basic mechanism involved in the pathophysiology of cystitis by characterizing the urodynamic parameters, pharmacologically relevant (muscarinic and purinergic) receptors, and the in vivo release of adenosine triphosphate (ATP) in the bladder of hydrochloric acid (HCl)-treated rats.
The muscarinic and purinergic receptors in rat tissue were measured by radioreceptor assays using (N-methyl-³H) scopolamine methyl chloride ([³H]NMS) and αβ-methylene-ATP (2,8-³H) tetrasodium salt ([³H]αβ-MeATP), respectively. The urodynamic parameters and ATP levels were measured using a cystometric method and the luciferin-luciferase assay, respectively.
In the HCl-treated rats, the micturition interval and micturition volume were significantly (48% and 55%, respectively, P <.05) decreased and the number of micturitions was significantly (3.2-fold, P <.05) increased compared with those of the control rats. The maximal number of binding sites for [³H]NMS and [³H]αβ-MeATP was significantly (55% and 72%, respectively, P <.001) decreased in the bladder of HCl-treated rats, suggesting downregulation of both muscarinic and purinergic receptors. In the HCl-treated rats, the inhibition constant, K(i), values for oxybutynin, solifenacin, and darifenacin were significantly (1.3-1.4-fold, P <.05) increased, but those for tolterodine and AF-DX116 were unchanged. Similarly, the inhibition constant for A-317491, pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid tetrasodium, and MRS2273 was significantly (5.5, 11, and 7.6-fold, respectively, P <.001) increased. Furthermore, the in vivo release of ATP was significantly (P <.05) enhanced in the HCl-treated rat bladder.
Both muscarinic and purinergic mechanisms might be, at least in part, associated with the urinary dysfunction due to cystitis.
通过对盐酸(HCl)处理大鼠膀胱中的尿动力学参数、药理学相关(毒蕈碱和嘌呤能)受体以及三磷酸腺苷(ATP)的体内释放进行特征描述,阐明膀胱炎病理生理学中的基本机制。
采用放射性受体分析方法,分别使用(N-甲基-³H)莨菪碱氯化物([³H]NMS)和αβ-亚甲基-ATP(2,8-³H)四钠盐([³H]αβ-MeATP)测量大鼠组织中的毒蕈碱和嘌呤能受体。使用膀胱测压法和荧光素-荧光素酶测定法分别测量尿动力学参数和 ATP 水平。
与对照组大鼠相比,HCl 处理大鼠的排尿间隔和排尿量分别显著(分别为 48%和 55%,P <.05)减少,排尿次数显著(3.2 倍,P <.05)增加。[³H]NMS 和 [³H]αβ-MeATP 的最大结合位点数量在 HCl 处理大鼠的膀胱中分别显著(55%和 72%,P <.001)减少,表明毒蕈碱和嘌呤能受体均下调。在 HCl 处理大鼠中,奥昔布宁、索利那新和达非那新的抑制常数(K i)值显著(1.3-1.4 倍,P <.05)增加,但托特罗定和 AF-DX116 不变。同样,A-317491、吡哆醛-6-偶氮苯-2',4'-二磺酸钠四钠盐和 MRS2273 的抑制常数分别显著(5.5、11 和 7.6 倍,P <.001)增加。此外,ATP 的体内释放在 HCl 处理大鼠的膀胱中显著(P <.05)增强。
毒蕈碱和嘌呤能机制至少部分与膀胱炎引起的尿功能障碍有关。